Skip to main content
Premium Trial:

Request an Annual Quote

Base Pair Biotechnologies Raises $3.2M

NEW YORK (GenomeWeb) – Base Pair Biotechnologies announced today that it has closed a $3.2 million Series A-3 financing round.

Base Pair provides custom aptamer discovery and development services, as well as a line of catalog aptamers. The company said it would use the financing to acquire new lab instruments and other technology in order to to expand its cellular and molecular analysis capabilities, as well as to expand its team.

Eventi Capital Partners and Base Pair Canada led the round, with participation from existing investors BioTex — a Houston-based biomedical technology accelerator that spun out Base Pair in 2012 — and BioTex President and CEO Ashok Gowda.